Breast cancer is subdivided into four clinical subtypes according to the presence/absence of hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2): HR-positive/HER2-negative, HR-positive/HER2-positive, HR-negative/HER2-positive, and triple-negative breast cancer (TNBC). This evidence concerns the gene ERBB2 and breast cancer.